Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company)

This study tested an oral drug called MORF-057 in 39 adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goal was to see if the drug was safe, tolerable, and could reduce disease activity over 12 weeks of treatment. Participants who c…